Literature DB >> 7127999

Kinetics and dynamics of furosemide and slow-acting furosemide.

B Beermann.   

Abstract

Bioavailability and dynamics of a sustained-release preparation of furosemide (FR, 60 mg) were compared with those of a conventional tablet (F, 40 mg). The preparations were given to 12 healthy subjects in a study of crossover randomized design once daily for a week. FR absorption was substantially delayed and the uptake of furosemide was about 75% of that from F, despite the larger dose administered. F induced a brief, intense diuresis and excretion of Na+, K+, and Cl-, both during short- and long-term administration. There was no such peak after FR. Total diuretic and saluretic effects did not differ between the two preparations, despite the lower bioavailability of FR. It is suggested that this discrepancy might be caused by transient supramaximal urinary levels of furosemide after F, whereby not all of the drug can exert an effect.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127999     DOI: 10.1038/clpt.1982.207

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

Review 1.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

2.  Reduced bioavailability and effect of furosemide given with food.

Authors:  B Beermann; C Midskov
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Pharmacodynamics and urine pharmacokinetics of three doses of piretanide.

Authors:  B H Meyer; F O Müller; H G Grigoleit; E E Dagrosa
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  The efficiency concept in pharmacodynamics.

Authors:  G Alván; G Paintaud; M Wakelkamp
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

5.  Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.

Authors:  G Alván; G Paintaud; S A Eckernäs; A Grahnén
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

6.  Bioavailability and elimination kinetics of the combination furosemide-retard/triamterene.

Authors:  O Schuster; D Loew; H E Knoell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Apr-Jun       Impact factor: 2.441

Review 7.  Influence of drug formulation on drug concentration-effect relationships.

Authors:  G Castañeda-Hernández; G Caillé; P du Souich
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

8.  Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis.

Authors:  M M Hammarlund; L K Paalzow; B Odlind
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.

Authors:  T Li; M G Lee; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1986-10

Review 10.  Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.

Authors:  M Hammarlund-Udenaes; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1989-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.